Cargando…
Superficial thrombophlebitis in ipsilateral breast after COVID-19 vaccination
On December 2020, the US Food and Drug Administration issued the first emergency use authorization for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We report development of superficial thrombophlebitis in...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189435/ https://www.ncbi.nlm.nih.gov/pubmed/35711742 http://dx.doi.org/10.1016/j.radcr.2022.05.018 |